LifeStance Health Group, Inc.LFSTEarnings & Financial Report
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
LFST Q4 FY2025 Key Financial Metrics
Revenue
$382.2M
Gross Profit
N/A
Operating Profit
$18.1M
Net Profit
$11.7M
Gross Margin
N/A
Operating Margin
4.7%
Net Margin
3.1%
YoY Growth
17.4%
LifeStance Health Group, Inc. Q4 FY2025 Financial Summary
LifeStance Health Group, Inc. reported revenue of $382.2M (up 17.4% YoY) for Q4 FY2025, with a net profit of $11.7M (up 264.1% YoY) (3.1% margin).
Key Financial Metrics
| Total Revenue | $382.2M |
|---|---|
| Net Profit | $11.7M |
| Gross Margin | N/A |
| Operating Margin | 4.7% |
| Report Period | Q4 FY2025 |
LifeStance Health Group, Inc. Annual Revenue by Year
LifeStance Health Group, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.4B).
LifeStance Health Group, Inc. Quarterly Revenue & Net Profit History
LifeStance Health Group, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $382.2M | +17.4% | $11.7M | 3.1% |
| Q3 FY2025 | $363.8M | +16.3% | $1.1M | 0.3% |
| Q2 FY2025 | $345.3M | +10.6% | $-3.8M | -1.1% |
| Q1 FY2025 | $333.0M | +10.8% | $709.0K | 0.2% |
| Q4 FY2024 | $325.5M | +16.0% | $-7.1M | -2.2% |
| Q3 FY2024 | $312.7M | +19.0% | $-6.0M | -1.9% |
| Q2 FY2024 | $312.3M | +20.3% | $-23.3M | -7.5% |
| Q1 FY2024 | $300.4M | +18.9% | $-21.1M | -7.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $300.4M | $312.3M | $312.7M | $325.5M | $333.0M | $345.3M | $363.8M | $382.2M |
| YoY Growth | 18.9% | 20.3% | 19.0% | 16.0% | 10.8% | 10.6% | 16.3% | 17.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.11B | $2.12B | $2.11B | $2.12B | $2.10B | $2.15B | $2.15B | $2.20B |
| Liabilities | $677.3M | $689.3M | $670.8M | $672.0M | $647.6M | $672.9M | $656.2M | $682.9M |
| Equity | $1.43B | $1.43B | $1.44B | $1.45B | $1.46B | $1.47B | $1.49B | $1.52B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-21.8M | $44.1M | $22.7M | $62.3M | $-3.1M | $64.4M | $27.3M | $57.6M |